Partner Content Partner Content Official Invitation from Chair of RNA Therapeutics 2019 Conf... Invitation from Chair of RNA Therapeutics 2019
Partner Content Partner Content Updates on Delivery Mechanisms of RNA-Based Drugs at RNA The... Updates on Delivery Mechanisms of RNA-Based Drugs
News FDA backs Curium's Bexlutry as 1st 'radioligand equivalent' Curium's copycat version of Novartis GEP-NET therapy Lutathera, Bexlutry, is the first radioligand equivalent (RLE) to be approved by the FDA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
